Quantitative analysis for Alpha Tau Medical Ltd. (DRTS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (65.0) (grade B). 28 signals analyzed (23 differentiated alt-data).
DRTS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $7.38 | $7.15 | $7.37 |
| 2026-05-11 | $10.80 | $9.25 | $10.34 |
| 2026-05-21 | $11.36 | $10.77 | $10.96 |
| 2026-06-03 | $11.00 | $9.22 | $10.58 |
| 2026-06-15 | $10.03 | $9.47 | $9.67 |
| 2026-06-26 | $11.30 | $10.61 | $10.88 |
| 2026-07-09 | $13.28 | $12.88 | $12.98 |
| 2026-07-21 | $13.80 | $12.65 | $13.32 |
| 2026-07-31 | $12.22 | $11.51 | $11.79 |
| 2026-08-12 | $14.40 | $13.41 | $13.87 |
| 2026-08-24 | $15.00 | $14.57 | $14.70 |
| 2026-09-03 | $15.07 | $14.32 | $14.62 |
How Alpha Tau Medical Ltd. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals, Inc. | $982M | — |
| CRON | Cronos Group Inc. | $998M | — |
| BTX | BlackRock Technology and Private Equity Term Trust | $1.0B | — |
| ALVO | Alvotech | $1.0B | — |
View all Health Care stocks by valuation and signals →
Alpha Tau Medical Ltd. (DRTS) scores Buy (65.0), with no measured dimension below 64. Its highest are ML forecast at 95, AI Alpha (gem) at 91, valuation at 72, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 95 |
| AI Alpha (gem) | 91 |
| valuation | 72 |
| analyst consensus | 66 |
| technicals | 64 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Alpha Tau Medical Ltd. (DRTS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/DRTS"><img src="https://stoquant.com/badge/DRTS.svg" alt="Alpha Tau Medical Ltd. (DRTS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.